Skip to main content
. 2016 Jul 18;11(7):e0159666. doi: 10.1371/journal.pone.0159666

Table 1. Effect of pyridoxamine and 17β-estradiol replacement on body, kidney, uterine weight and albumin/creatinine ratio.

Pla (n = 10) E2 (n = 12) Pyr (n = 10) Pyr+E2 (n = 6)
Body weight (g) 31 ±1.3 30±0.9 31±1.5 30±1.4
Kidney weight (g) 0.28±0.01 0.29±0.01 0.27±0.009 0.34±0.2 a
Uterine weight (g) 0.02±0.00b 0.14±0.02c 0.02±0.001d 0.15±0.02
Albumin/Creatinine ratio 0.43±0.32 0.26±0.06 0.34±0.06 0.25±0.05

a *p<0.05 compared to placebo (pla) and pyridoxamine (Pyr)

b***p<0.005 compared to 17β-estradiol (E2) and Pyr+E2

c***p<0.005 compared to Pyr

d ***p<0.005 compared to Pyr+E2.